May 2015
·
39 Reads
·
18 Citations
Presently the arsenal of anti-malarial drugs is limited and needs to be replenished. We evaluated the potential anti-malarial activity of two water soluble derivatives of nocathiacin (BMS461996 and BMS411886) against asexual blood stages of Plasmodium falciparum. Nocathiacins are a thiazolyl peptide group of antibiotics, structurally related to thiostrepton, have potent activity against a wide spectrum of multi drug resistant gram positive bacteria, and inhibit protein synthesis. We evaluated the potential anti-malarial activity of the derivatives of nocathiacin (BMS461996 and BMS411886) against asexual blood stages of Plasmodium falciparum. The in vitro growth inhibition assay was done using three laboratory strains of P. falciparum displaying varying levels of chloroquine (CQ) susceptibility. Our results indicates that, BMS461996 has potent anti-malarial activity and inhibits parasite growth with mean IC50 of 51.55 nM for P. falciparum 3D7 (CQ susceptible), 85.67 nM for P. falciparum Dd2 (accelerated resistance to multiple drugs, ARMD) and 99.44 nM for P.falciparum K1 strain (resistant to CQ, pyrimethamine and sulfadoxine). Similar results at approximately 7-fold higher IC50 values were obtained with BMS411886 in comparison to BMS461996. We also tested the effect of BMS491996 on gametocytes, our results show that at 20 fold excess of mean IC50 concentration, gametocytes were deformed with a pyknotic nucleus and growth of stage I-IV gametocytes was arrested. This preliminary study shows significant potential for nocathiacin analogues to be developed as anti-malarial drug candidates and warrants further investigation. Copyright © 2015, American Society for Microbiology. All Rights Reserved.